$NEO News

NeoGenomics Launches PTEN IHC CDx, Immunohistochemistry Companion Diagnostic Test Approved By FDA For Patients With Prostate Adenocarcinoma

A Look Back at Testing & Diagnostics Services Stocks’ Q1 Earnings: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Pack

NeoGenomics Appoints Carolyn Starrett to its Board of Directors

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes

NeoGenomics Prices Offering Of $275M Of 0.75% Convertible Senior Notes Due 2032

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes

NeoGenomics Commences A Private Offering Of $275M Aggregate Principal Amount Of Convertible Senior Notes Due 2032

Is NeoGenomics (NEO) Using Its ASCO ctDNA Focus To Redefine Its Precision Oncology Edge?

NeoGenomics to Present New Research at ASCO Annual Meeting 2026

NeoGenomics To Showcase Eight Scientific Abstracts, Highlighting Advances In MRD, Precision Oncology, And Real-World Evidence Across Solid Tumors And Hematologic Malignancies, At 2026 ASCO Annual Meeting

NeoGenomics to Participate in Upcoming Investor Conferences

A Look At NeoGenomics (NEO) Valuation After Q1 2026 Results And Epic Aura Oncology Integration

Benchmark Upgrades NeoGenomics to Buy, Announces $11 Price Target

TD Cowen Maintains Buy on NeoGenomics, Raises Price Target to $14

NeoGenomics Shares Jump on Earnings and Analyst Upgrades

Leerink Partners Upgrades NeoGenomics to Outperform, Raises Price Target to $25

NeoGenomics Inc (NEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

NeoGenomics, Inc. (NEO) Q1 2026 Earnings Call Transcript

NeoGenomics Inc (NASDAQ:NEO) Crushes Estimates on Robust Clinical Growth, Launches Novel MRD Test

NeoGenomics Q1 Earnings Call Highlights